Home > Alcohol screening among opioid agonist patients in a primary care clinic and an opioid treatment program.

Klimas, Jan and Muench, John and Wiest, Katharina and Croff, Raina and Rieckman, Traci and McCarty, Dennis (2015) Alcohol screening among opioid agonist patients in a primary care clinic and an opioid treatment program. Journal of Psychoactive Drugs , 47 , (1) , pp. 65-70.

Problem alcohol use is associated with adverse health and economic outcomes, especially among people in opioid agonist treatment. Screening, brief intervention, and referral to treatment (SBIRT) are effective in reducing alcohol use; however, issues involved in SBIRT implementation among opioid agonist patients are unknown. To assess identification and treatment of alcohol use disorders, we reviewed clinical records of opioid agonist patients screened for an alcohol use disorder in a primary care clinic (n = 208) and in an opioid treatment program (n = 204) over a two-year period. In the primary care clinic, 193 (93%) buprenorphine patients completed an annual alcohol screening and six (3%) had elevated AUDIT scores. In the opioid treatment program, an alcohol abuse or dependence diagnosis was recorded for 54 (27%) methadone patients. Practitioner focus groups were completed in the primary care (n = 4 physicians) and the opioid treatment program (n = 11 counselors) to assess experience with and attitudes towards screening opioid agonist patients for alcohol use disorders. Focus groups suggested that organizational, structural, provider, patient, and community variables hindered or fostered alcohol screening. Alcohol screening is feasible among opioid agonist patients. Effective implementation, however, requires physician training and systematic changes in workflow.


Item Type:Article
Date:2015
Page Range:pp. 65-70
Volume:47
Number:1
EndNote:View
Accession Number:HRB (Available)
Subjects:A Substance use, abuse, and dependence > Prevalence > Problem substance use
B Substances > Opioids (opiates)
B Substances > Opioids (opiates) > Opioid product > Methadone
G Health and disease > Substance use disorder > Alcohol use
J Health care, prevention and rehabilitation > Identification and screening > Identification and screening for substance use
J Health care, prevention and rehabilitation > Health care programme or facility > Community-based treatment (primary care)
T Demographic characteristics > Person who uses substances (user)
VA Geographic area > Europe > Ireland

Click here to request a copy of this literature (must be logged in)

Repository Staff Only: item control page